Madrigal Pharmaceuticals’ Rezdiffra Shows Strong Market Growth and Positive Outlook, Justifying Buy Rating
Analyst Jonathan Wolleben of JMP Securities reiterated a Buy rating on Madrigal Pharmaceuticals (MDGL – Research Report), with a price target ...
Benzinga.com2mon
Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock Quotes, Forecast and News Summary
Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon Recent sales of a little-known stock, Madrigal Pharmaceuticals (NASDAQ:MDGL), could bode well for Novo Nordisk A/S (NYSE:NVO). The pharma ...
Bank of America Securities Remains a Sell on Madrigal Pharmaceuticals (MDGL)
Bank of America Securities analyst Jason Zemansky maintained a Sell rating on Madrigal Pharmaceuticals (MDGL – Research Report) today and set a ...